Maternal HLA-C2 and 14bp insertion in HLA-G is associated with recurrent implantation failure after in vitro fertilization treatment

Tissue Antigens

Volumn 84, Issue 6, 2014, Pages 536-544

  Lashley, L E E L O ^a   van der Westerlaken, L A J ^a   Haasnoot, G W ^a   Drabbels, J J M ^a   Spruyt Gerritse, M J ^a   Scherjon, S A ^b   Claas, F H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Histocompatibility; HLA C; HLA G; in vitro fertilization; Killer cell immunoglobulin like receptors; Recurrent implantation failure

Indexed keywords

HLA C ANTIGEN; HLA G ANTIGEN;

ADULT; ALLELE; CLINICAL TRIAL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE FREQUENCY; GENETICS; HAPLOTYPE; HUMAN; IMMUNOLOGY; INDEL MUTATION; NIDATION; RISK FACTOR;

ADULT; ALLELES; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; GENE FREQUENCY; HAPLOTYPES; HLA-C ANTIGENS; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; INFERTILITY, FEMALE; RISK FACTORS;

EID: 84911441795     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12452     Document Type: Article

References (67)

1. Andersen AN, Gianaroli L, Felberbaum R, de MJ, Nygren KG. Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod 2005: 20: 1158-76.
2. Santos MA, Kuijk EW, Macklon NS. The impact of ovarian stimulation for IVF on the developing embryo. Reproduction 2010: 139: 23-34.
3. Boomsma CM, Macklon NS. What can the clinician do to improve implantation? Reprod Biomed Online 2006: 13: 845-55.
4. Scherjon S, Lashley L, van der Hoorn ML, Claas F. Fetus specific T cell modulation during fertilization, implantation and pregnancy. Placenta 2011: 32 (Suppl 4): S291-7.
5. Jenkins C, Roberts J, Wilson R, MacLean MA, Shilito J, Walker JJ. Evidence of a T(H) 1 type response associated with recurrent miscarriage. Fertil Steril 2000: 73: 1206-8.
6. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998: 4: 1020-4.
7. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991: 6: 294-8.
8. Moldenhauer LM, Diener KR, Thring DM, Brown MP, Hayball JD, Robertson SA. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol 2009: 182: 8080-93.
9. Komlos L, Zamir R, Joshua H, Halbrecht I. Common HLA antigens in couples with repeated abortions. Clin Immunol Immunopathol 1977: 7: 330-5.
10. Balasch J, Jove I, Martorell J, Gaye A, Vanrell JA. Histocompatibility in in vitro fertilization couples. Fertil Steril 1993: 59: 456-8.
11. Weckstein LN, Patrizio P, Balmaceda JP, Asch RH, Branch DW. Human leukocyte antigen compatibility and failure to achieve a viable pregnancy with assisted reproductive technology. Acta Eur Fertil 1991: 22: 103-7.
12. Creus M, Balasch J, Fabregues F et al. Parental human leukocyte antigens and implantation failure after in-vitro fertilization. Hum Reprod 1998: 13: 39-43.
13. Varla-Leftherioti M, Keramitsoglou T, Spyropoulou-Vlachou M et al. 14th International HLA and Immunogenetics Workshop: report from the reproductive immunology component. Tissue Antigens 2007: 69 (Suppl 1): 297-303.
14. Jin K, Ho HN, Speed TP, Gill TJ III. Reproductive failure and the major histocompatibility complex. Am J Hum Genet 1995: 56: 1456-67.
15. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008: 23: 972-6.
16. Hiby SE, Apps R, Sharkey AM et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010: 120: 4102-10.
17. Hiby SE, Walker JJ, O'shaughnessy KM et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004: 200: 957-65.
18. Varla-Leftherioti M, Keramitsoglou T, Parapanissiou E et al. HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop. Tissue Antigens 2010: 75: 668-72.
19. Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004: 64: 66-9.
20. Costa CH, Gelmini GF, Wowk PF et al. HLA-G regulatory haplotypes and implantation outcome in couples who underwent assisted reproduction treatment. Hum Immunol 2012: 73: 891-7.
21. Sipak-Szmigiel O, Cybulski C, Wokolorczyk D et al. HLA-G polymorphism and in vitro fertilization failure in a Polish population. Tissue Antigens 2009: 73: 348-52.
22. Verduyn W, Doxiadis II, Anholts J et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993: 37: 59-67.
23. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination I. Description of the algorithm. Hum Immunol 2002: 63: 339-52.
24. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 2002: 59: 184-93.
25. Beydoun H, Saftlas AF. Association of human leucocyte antigen sharing with recurrent spontaneous abortions. Tissue Antigens 2005: 65: 123-35.
26. Sargent IL, Borzychowski AM, Redman CWG. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online 2006: 13: 680-6.
27. Ober C, Steck T, van dV et al. MHC class II compatibility in aborted fetuses and term infants of couples with recurrent spontaneous abortion. J Reprod Immunol 1993: 25: 195-207.
28. Poli F, Scalamogna M, Crespiatico L et al. Comparison of serological and molecular typing for HLA-A and -B on cord blood lymphocytes. Tissue Antigens 1998: 51: 67-71.
29. Woszczek G, Borowiec M, Mis M, Gorska M, Kowalski ML. Comparison of serological and molecular (PCR-SSP) techniques of HLA-DR typing in clinical laboratory routine. Ann Transplant 1997: 2: 39-42.
30. Kostyu DD. HLA: fertile territory for developmental genes? Crit Rev Immunol 1994: 14: 29-59.
31. Choudhury SR, Knapp LA. Human reproductive failure II: immunogenetic and interacting factors. Hum Reprod Update 2001: 7: 135-60.
32. Saftlas AF, Beydoun H, Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 2005: 106: 162-72.
33. Omu AE, al-Qattan F, Bukhadour N. Human leucocyte antigens in pregnant women with pre-eclampsia associated with intrauterine growth retardation and in normal controls. Arch Gynecol Obstet 1998: 261: 129-37.
34. Duquesnoy RJ. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int J Immunogenet 2012: 39: 1-9.
35. Dankers MK, Witvliet MD, Roelen DL et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004: 77: 1236-9.
36. Lashley EE, Meuleman T, Claas FH. Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis. Am J Reprod Immunol 2013: 70: 87-103.
37. Stephenson MD, Fluker MR. Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial. Fertil Steril 2000: 74: 1108-13.
38. Flores AC, Marcos CY, Paladino N et al. KIR receptors and HLA-C in the maintenance of pregnancy. Tissue Antigens 2007: 69 (Suppl 1): 112-3.
39. Witt CS, Goodridge J, Gerbase-Delima MG, Daher S, Christiansen FT. Maternal KIR repertoire is not associated with recurrent spontaneous abortion. Hum Reprod 2004: 19: 2653-7.
40. Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D et al. Natural killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol 2003: 49: 183-91.
41. Parham P, Guethlein LA. Pregnancy immunogenetics: NK cell education in the womb? J Clin Invest 2010: 120: 3801-4.
42. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008: 29: 313-21.
43. Hunt JS, Langat DK, McIntire RH, Morales PJ. The role of HLA-G in human pregnancy. Reprod Biol Endocrinol 2006: 4 (Suppl): S1-10.
44. Rebmann V, Pfeiffer K, Passler M et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999: 53: 14-22.
45. Larsen MH, Bzorek M, Pass MB et al. Human leukocyte antigen-G in the male reproductive system and in seminal plasma. Mol Hum Reprod 2011: 17: 727-38.
46. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004: 56: 135-41.
47. Lynge NL, Djurisic S, Hviid TV. Controlling the immunological crosstalk during conception and pregnancy: HLA-G in reproduction. Front Immunol 2014: 5: 198.
48. Solier C, Aguerre-Girr M, Lenfant F et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002: 32: 3576-86.
49. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001: 98: 12150-5.
50. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000: 101: 191-200.
51. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2006: 12: 209-32.
52. Yie S, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005: 193: 204-8.
53. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007: 57: 277-86.
54. Rizzo R, Andersen AS, Lassen MR et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009: 62: 320-38.
55. Pfeiffer KA, Rebmann V, Passler M et al. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000: 61: 559-64.
56. Rebmann V, van dV, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001: 57: 15-21.
57. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63-79.
58. Rizzo R, Hviid TV, Govoni M et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008: 71: 520-9.
59. Nardi FS, Slowik R, Wowk PF et al. Analysis of HLA-G polymorphisms in couples with implantation failure. Am J Reprod Immunol 2012: 68: 507-14.
60. Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006: 67: 53-62.
61. Ober C, Aldrich CL, Chervoneva I et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003: 72: 1425-35.
62. Suryanarayana V, Rao L, Kanakavalli M et al. Association between novel HLA-G genotypes and risk of recurrent miscarriages: a case-control study in a South Indian population. Reprod Sci 2008: 15: 817-24.
63. Penzias AS. Recurrent IVF failure: other factors. Fertil Steril 2012: 97: 1033-8.
64. Saravelos SH, Li TC. Unexplained recurrent miscarriage: how can we explain it? Hum Reprod 2012: 27: 1882-6.
65. Fuzzi B, Rizzo R, Criscuoli L et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002: 32: 311-5.
66. Noci I, Fuzzi B, Rizzo R et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005: 20: 138-46.
67. Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome. Reprod Biomed Online 2004: 9: 74-8.